B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Gsk 2636771

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Gsk 2636771, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

zstk
3 shared targets
gedatolisib
3 shared targets
duvelisib
2 shared targets
bimiralisib
3 shared targets
voxtalisib
2 shared targets
sapanisertib
2 shared targets
idelalisib
2 shared targets
pilaralisib
2 shared targets
eganelisib
2 shared targets
buparlisib
3 shared targets
Loading evidence profile...

This evidence profile for Gsk 2636771 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.